DOI QR코드

DOI QR Code

Malignant Transformation Rate and P53, and P16 Expression in Teratomatous Skin of Ovarian Mature Cystic Teratoma

  • Zhu, Hai-Li (Department of Pathology, Nanfang Hospital, Southern Medical University) ;
  • Zou, Zhen-Ning (Department of Pathology, Nanfang Hospital, Southern Medical University) ;
  • Lin, Pei-Xin (Department of Pathology, Nanfang Hospital, Southern Medical University) ;
  • Li, Wen-Xia (Department of Pathology, Nanfang Hospital, Southern Medical University) ;
  • Huang, Ye-En (Department of Pathology, Nanfang Hospital, Southern Medical University) ;
  • Shi, Xiao-Xin (Department of Pathology, Nanfang Hospital, Southern Medical University) ;
  • Shen, Hong (Department of Pathology, Nanfang Hospital, Southern Medical University)
  • Published : 2015.03.04

Abstract

Objective: To investigate the incidence of malignant transformation and P53 and P16 expression in teratomatous skin of ovarian mature cystic teratoma. Materials and Methods: Data on ovarian teratoma specimens in nearly 10 years were reviewed. P53 and P16 expression were detected by immunohistochemistry in 25 cases of teratomatous skin of ovarian mature cystic teratoma, 20 cases of squamous cell carcinoma and 2 cases of squamous cell carcinoma originated from teratomatous skin. Results: Of 1913 cases of ovarian mature cystic teratoma in nearly 10 years, only two cases of squamous cell carcinoma were found in teratomatous skin, with malignant transformation rate of 0.1045%. P53 expression was detected in 2 cases squamous cell carcinoma originated from teratomatous skin and P16 overexpression in one. There were no expressions of P53 and P16 in 25 cases of teratomatous skin of ovarian mature cystic teratoma. Of 20 cases of squamous cell carcinoma P53 overexpression (positive rate of 55%) was detected in 11 cases, P16 overexpression (positive rate of 35%) in 7 cases. The positive rates of P53 and P16 expression in squamous cell carcinomas were significantly higher than that in the teratomatous skins (p< 0.001, p= 0.002). Conclusions: There was low risk of malignant transformation in teratomatous skin of ovarian mature cystic teratoma which can be explained by lower P53 and P16 expressionin teratomas than that in squamous cell carcinoma.

Keywords

Teratoma-malignant transformation;p53-p16;immunohistochemistry;squamous cell carcinoma

Acknowledgement

Supported by : National Natural Science Foundation of China

References

  1. Ayhan A, Bukulmez O, Genc C, et al (2000). Mature cystic teratomas of the ovary: case series from one institution over 34 years. Eur J Obstet Gynecol Reprod Biol, 88,153-7. https://doi.org/10.1016/S0301-2115(99)00141-4
  2. Chang SD, Yen CF, Lo LM, et al (2011). Surgical intervention for maternal ovarian torsion in pregnancy. Taiwan J Obstet Gynecol, 50, 458-62. https://doi.org/10.1016/j.tjog.2011.10.010
  3. Climie AR, Heath LP (1968). Malignant degeneration of benign cystic teratomas of the ovary. Review of the literature and report of a chondrosarcoma and carcinoid tumor. Cancer, 22, 824-32. https://doi.org/10.1002/1097-0142(196810)22:4<824::AID-CNCR2820220421>3.0.CO;2-J
  4. Cabibi D, Martorana A, Cappello F, et al (2006). Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report. BMC Cancer, 1, 46-47.
  5. Dos Santos L, Mok E, Iasonos A, et al (2007). Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol, 105, 321-4. https://doi.org/10.1016/j.ygyno.2006.12.008
  6. Fearon ER, Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-67. https://doi.org/10.1016/0092-8674(90)90186-I
  7. Guney N, Sayilgan T, Derin D, et al (2009). Primary carcinoid tumor arising in a mature cystic teratoma of the ovary: a case report. Eur J Gynaecol Oncol, 30, 223-5.
  8. Fox H (1965). Bronchial carcinoma in an ovarian cystic teratoma (dermoid). J Clin Pathol, 1965, 18, 164-6. https://doi.org/10.1136/jcp.18.2.164
  9. Fujii T, Oguni S, Kikuchi M, et al (1995). p53 mutation in carcinomas arising in ovarian cystic teratomas. Pathol Int, 1995, 45, 649-54. https://doi.org/10.1111/j.1440-1827.1995.tb03517.x
  10. Hodges A, Smoller BR (2002). Immunohistochemical Comparison of P16 Expression in. Actinic Keratoses and Squamous Cell Carcinomas of the Skin. Mod Pathol, 15, 1121-5. https://doi.org/10.1097/01.MP.0000032536.48264.D1
  11. Hackethal A, Brueggmann D, Bohlmann MK, et al (2008). Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. Lancet Oncology, 9, 1173-80. https://doi.org/10.1016/S1470-2045(08)70306-1
  12. Hirakawa T, Tsuneyoshi M, Enjoji M (1989). Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Am J Surg Pathol, 13, 397-405. https://doi.org/10.1097/00000478-198905000-00007
  13. Hyun HS, Mun ST (2013). Primary malignant melanoma arising in a cystic teratoma. Obstet Gynecol Sci, 56, 201-4. https://doi.org/10.5468/ogs.2013.56.3.201
  14. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
  15. Ikota H, Kaneko K, Takahashi S, et al (2012). Malignant transformation of ovarian mature cystic teratoma with a predominant pulmonary type small cell carcinoma component. Pathol Int, 62, 276-80. https://doi.org/10.1111/j.1440-1827.2012.02804.x
  16. Klionsky BL, Nickens OJ, Amortegui AJ (1972). Squamous cell carcinoma in situ arising in adult cystic teratoma of the ovary. Arch. Pathol, 93, 161-3.
  17. Kappes S, Milde-Langosch K, Kressin P, et al (1995). p53 mutations in ovarian tumors, detected by temperaturegradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer, 64, 52-9. https://doi.org/10.1002/ijc.2910640111
  18. Li YM, Wan LY, Shen H (2011). Wood grain redyeing effects on quantitative analysis of immunohistochemical staining density. J Tropical Med, 11, 553-5.
  19. Muramatsu T, Nishii T, Ohmori K, et al (2011). Mature cystic teratoma with malignant transformation to adenocarcinoma. Ann Thorac Surg, 91, 1971-3. https://doi.org/10.1016/j.athoracsur.2010.11.025
  20. Oda Y, Sakamoto A, Saito T, et al (2000). Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Mod Pathol, 13, 994-1004. https://doi.org/10.1038/modpathol.3880180
  21. Outwater EK, Siegelman ES, Hunt JL (2001). Ovarian teratomas, tumor types and imaging characteristics. Radiographics, 21, 475-490. https://doi.org/10.1148/radiographics.21.2.g01mr09475
  22. Peterson WF (1957). Malignant degeneration of benign cystic teratomas of the overy: a collective review of the literature. Obstet Gynecol Surv, 12, 793-830. https://doi.org/10.1097/00006254-195712000-00001
  23. Park JY, Kim DY, Kim JH, et al (2008). Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. Eur J Obstet Gynecol Reprod Biol, 141, 173-8. https://doi.org/10.1016/j.ejogrb.2008.07.032
  24. Palazzo JP, Monzon F, Burke M, et al (2000). Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors. Hum Pathol, 31, 698-704. https://doi.org/10.1053/hupa.2000.7641
  25. Ribeiro-Silva A, Chang D, Bisson FW, et al (2003). Clinicopathological and immunohistochemical features of a sebaceous carcinoma arising within a benign dermoid cyst of the ovary. Virchows Arch, 443, 574-8. https://doi.org/10.1007/s00428-003-0854-7
  26. Rha SE, Byun JY, Jung SE, et al (2004). Atypical CT and MRI manifestations of mature ovarian cystic teratomas. AJR Am J Roentgenol, 183, 743-50. https://doi.org/10.2214/ajr.183.3.1830743
  27. Stamp GW, McConnell EM (1983). Malignancy arising in cystic ovarian teratomas. A report of 24 cases. Br J Obstet Gynaecol, 90, 671-5. https://doi.org/10.1111/j.1471-0528.1983.tb09289.x
  28. Sumi T, Ishiko O, Yoshida H, et al (2001). Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation. Int J Mol Med, 8, 495-8.
  29. Sherr CJ (1993). Mammalian G1 cyclins. Cell, 73, 1059-65.
  30. Takahashi H, Chaopotong P, Kajita S, et al (2012). Mixed angiosarcoma, clear cell adenocarcinoma and mature teratoma elements in an ovarian tumor: A case report and literature review. Pathol Int, 62, 538-42. https://doi.org/10.1111/j.1440-1827.2012.02831.x
  31. Ulbright TM (2005). Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol, 18, 61-79. https://doi.org/10.1038/modpathol.3800310
  32. Weber A, Bellmann U, Bootz F (2002). INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Virchows Arch, 441, 133-142. https://doi.org/10.1007/s00428-002-0637-6
  33. Yoshioka T, Tanaka T (1998). Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary. J Obstet Gynaecol Res, 24, 83-90. https://doi.org/10.1111/j.1447-0756.1998.tb00057.x

Cited by

  1. Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1093
  2. Mature Cystic Teratoma of the Ovary With Three Kinds of Entire Gastrointestinal Wall and Complete Bronchial Structure in a Pregnant Woman vol.24, pp.5, 2016, https://doi.org/10.1177/1066896916628280